Morris R G, Tett S E, Ray J E
Department of Clinical Pharmacology, Queen Elizabeth Hospital, Woodville South, South Australia.
Ther Drug Monit. 1994 Dec;16(6):570-6. doi: 10.1097/00007691-199412000-00007.
Cyclosporin-A (CsA) therapeutic drug monitoring plays an integral role in therapeutic management of immunosuppressed patients, including those with organ transplants. This communication, prepared by an Australian team, presents recommendations for the routine monitoring of CsA, including blood sampling methodological approaches and interpretation of results generated. The consensus approach described is intended to address the diversity of attitudes to CsA monitoring demonstrated in a recent national survey of Australian laboratories that provide CsA analyses.
环孢素A（CsA）治疗药物监测在免疫抑制患者（包括器官移植患者）的治疗管理中起着不可或缺的作用。这份由一个澳大利亚团队撰写的报告提出了CsA常规监测的建议，包括血样采集方法和对所产生结果的解读。所描述的共识方法旨在解决近期对提供CsA分析的澳大利亚实验室进行的全国性调查中所显示出的对CsA监测的不同态度。
